Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs Obu Health

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Obu Health a 70. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

Obu Health

#246 · Grade C · Watch List

Est. first month

From $190/mo (starting dose, plus a separate fee, compounded)

Save ~86% vs brand-name
Get this deal Full Obu Health review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 70 an est. $99/mo first month, with no teaser step-up baked in. Obu Health isn't out of it: Shoppers who want compounded GLP-1 plus peptide add-ons with named 503A pharmacies.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDObu Health
Value Score89 (A)70 (C)
Est. first month$99/moFrom $190/mo (starting dose, plus a separate fee, compounded)
Save vs brand-name~93%~86%
Semaglutide$99/moFrom $190/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$139/moFrom $239/mo (starting dose, plus a separate fee, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
74
bmiMD: 95. Obu Health: 74.
84
No Teaser-Rate Bait
64
bmiMD: 84. Obu Health: 64.
98
Nationwide Availability
45
bmiMD: 98. Obu Health: 45.
94
Both Molecules
92
bmiMD: 94. Obu Health: 92.
82
Easy Cancellation
68
bmiMD: 82. Obu Health: 68.
70
Reputation
78
bmiMD: 70. Obu Health: 78.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

Obu Health

Obu Health is a Las Vegas-based multi-product telehealth platform offering compounded semaglutide from $190/month and compounded tirzepatide from $239/month, plus NAD+ and sermorelin add-ons.

Why it's a deal

  • LegitScript-certified with publicly displayed ID (44206977)
  • Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
  • Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
  • Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
  • 24-hour US board-certified physician response window

The fine print

  • Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
  • No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
  • Medical director not named publicly
  • No published consultation fee disclosure — unclear whether physician visit is included in medication price
  • All sales final per FAQ ('Federal and State law do not allow medication returns')
Get the bmiMD deal Get the Obu Health deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Obu Health.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.